OA08424A - New conjugates of vinblastine and its derivatives, process for their preparation and pharmaceutical compositions containing these conjugates. - Google Patents

New conjugates of vinblastine and its derivatives, process for their preparation and pharmaceutical compositions containing these conjugates.

Info

Publication number
OA08424A
OA08424A OA58971A OA58971A OA08424A OA 08424 A OA08424 A OA 08424A OA 58971 A OA58971 A OA 58971A OA 58971 A OA58971 A OA 58971A OA 08424 A OA08424 A OA 08424A
Authority
OA
OAPI
Prior art keywords
conjugates
vinblastine
image
derivatives
group
Prior art date
Application number
OA58971A
Other languages
French (fr)
Inventor
Andre Benoit Leon Trouet
Kandukuri Sivapras Bushana Rao
Jean-Alfred Alphonse Hannart
Jean-Paul Dejonghe
Original Assignee
Omnichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU86157A external-priority patent/LU86157A1/en
Application filed by Omnichem Sa filed Critical Omnichem Sa
Publication of OA08424A publication Critical patent/OA08424A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid

Landscapes

  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Previously unknown conjugates of vinblastine, or derivatives thereof, have the general formula <IMAGE> where A denotes an "arm" such as <IMAGE> or <IMAGE> where n is an integer from 1-5 and R is a hydrogen atom or an acyl group, R1 is an optionally modified protein radical, R2 is a methoxy group, an amino group or an α-amino acid ester which is bonded using a bond of the amide type and where the ester group contains 1-6 carbon atoms, and where R3 is a hydrogen atom or an hydroxyl group and is in all cases in the two possible configurations. These conjugates have a powerful effect when treating leukaemias, lymphosarcomas and other malignant tumours, including the so-called "solid" tumours, and when treating Hodgkin's disease.
OA58971A 1985-11-12 1986-10-07 New conjugates of vinblastine and its derivatives, process for their preparation and pharmaceutical compositions containing these conjugates. OA08424A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU86157A LU86157A1 (en) 1985-11-12 1985-11-12 NEW PROCESS FOR THE MANUFACTURE OF VINBLASTIN CONJUGATES AND DERIVATIVES THEREOF
EP86870042A EP0222722B1 (en) 1985-11-12 1986-04-08 Conjugates of vinblastine and its derivatives, process for preparing them and pharmaceutical compositions containing these conjugates

Publications (1)

Publication Number Publication Date
OA08424A true OA08424A (en) 1988-06-30

Family

ID=26106792

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58971A OA08424A (en) 1985-11-12 1986-10-07 New conjugates of vinblastine and its derivatives, process for their preparation and pharmaceutical compositions containing these conjugates.

Country Status (6)

Country Link
AT (1) ATE89567T1 (en)
AU (1) AU577206B2 (en)
DK (1) DK164107C (en)
GR (1) GR862436B (en)
HU (1) HU196217B (en)
OA (1) OA08424A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508905B1 (en) * 1981-07-01 1984-01-27 Roussel Uclaf
CA1285866C (en) * 1984-10-19 1991-07-09 Akiko Kubodera Immunoassay for estriol-3-sulfate
ZA873600B (en) * 1986-05-27 1988-12-28 Lilly Co Eli Immunoglobulin conjugates
US5094849A (en) * 1988-08-08 1992-03-10 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR81790B (en) * 1983-04-29 1984-12-12 Omnichem Sa

Also Published As

Publication number Publication date
GR862436B (en) 1986-12-23
AU6340186A (en) 1988-04-14
HUT42493A (en) 1987-07-28
DK164107C (en) 1992-10-05
HU196217B (en) 1988-10-28
DK473286A (en) 1987-05-13
ATE89567T1 (en) 1993-06-15
DK164107B (en) 1992-05-11
DK473286D0 (en) 1986-10-03
AU577206B2 (en) 1988-09-15

Similar Documents

Publication Publication Date Title
EP0124502B1 (en) Conjugates of vinblastine and its derivatives, process for their preparation and pharmaceutical compositions containing these conjugates
NO169290C (en) ANALOGY PROCEDURE FOR PREPARING A THERAPEUTIC ACTIVE TETRAPYRROL-AMINO-DICARBOXYLIC ACID ADD
OA06421A (en) Process for the preparation of N- (vinblastinoyl-23) derivatives of amino acids and peptides.
OA08182A (en) New peptide derivatives with a nitrogenous polycyclic structure, their method of preparation and the pharmaceutical compositions which contain them.
EA200000592A1 (en) AZAPOLICYCLIC COMPOUNDS CONDENSED WITH ARYL
OA07508A (en) New xantine derivatives, their preparation process and pharmaceutical compositions containing them.
FR2639349B1 (en) NOVEL CHROMANE DERIVATIVES ACTIVE IN THE CENTRAL NERVOUS SYSTEM, THEIR PREPARATION METHOD AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2754258B1 (en) AMINOTHIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
OA08825A (en) New derivatives of the amino-tetrahydro-5,6,7,8 naphtho (2,3b) furan, their preparation processes and the pharmaceutical compositions which contain them.
OA09454A (en) New peptide derivatives, their preparation process and pharmaceutical compositions which contain them.
OA08424A (en) New conjugates of vinblastine and its derivatives, process for their preparation and pharmaceutical compositions containing these conjugates.
FR2707085B1 (en) New alpha amino acid derivatives, process for their preparation and pharmaceutical compositions containing them.
FR2707089B1 (en) New phosphonic acid derivatives, process for their preparation and pharmaceutical compositions containing them.
OA09349A (en) &#34;New derivatives of 3-aminochromane, their preparation process and pharmaceutical compositions which contain them&#34;.
FR2655043B1 (en) NOVEL THIOPHENE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
OA07589A (en) New derivatives of nitrosourea and their preparation.
FR2701952B1 (en) New cyclopeptide derivatives of angiopeptin, their preparation process and the pharmaceutical compositions containing them.
OA07495A (en) New cephalosporin derivatives, their preparation process and antibiotic drugs containing said derivatives
OA09476A (en) &#34;New derivatives of substituted amino acids, their preparation process and pharmaceutical compositions which contain them&#34;.
OA09451A (en) &#34;New derivatives of pyrrolidone, their preparation process and pharmaceutical compositions containing them&#34;.
OA09299A (en) New derivatives N- (vincristinoyl-23) and N- (noranhydro-5 &#39;vinblastinoyl-23) of animo-1 methylphosphonic acid, their preparation process and the pharmaceutical compositions which contain them.
LU84784A1 (en) NOVEL PROTEIN CONJUGATES OF VINBLASTIN, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC USE
MX4658E (en) PROCEDURE FOR PREPARING 3-CEFEM-4-CARBOXYLIC ACID COMPOUNDS 3.7 DISUBSTITUTED
KR910002787A (en) Acrylic acid amide derivatives, preparation methods thereof, pharmacological compositions containing them and drugs using them